News

Some looking at Zoetis

Canadian pharmaceutical company Valeant has made a preliminary approach to buy Zoetis.  Wall Street Journal says analysts have long considered Zoetis to be a takeover target.  Speculation is that others including Bayer AG are interested in the animal health company as well.

Zoetis was formed in 2013 when Pfizer spun-off its animal health business into a stand-alone company.  Zoetis sales totaled $4.8 billion in 2014, a five-percent increase from the previous year.  With headquarters in New Jersey, Zoetis has more than 300 product lines and 27 manufacturing facilities.  The company sells products in more than 120 countries.

With corporate headquarters in Laval, Quebec: Valeant Pharmaceuticals International specializes in dermatology, eye health, neurology and consumer health care.  Total sales were $8.25 billion in 2014.  With manufacturing sites in Canada, Mexico, Brazil and Poland products are sold in North America, Latin America, Europe, the Middle East and Asia Pacific.